Analogues of thiolactomycin as potential antimalarial agents

Area of Science:

• Medicinal Chemistry
• Parasitology
• Biochemistry

Background:

• Thiolactomycin (TLM) is a natural antibiotic that inhibits type II fatty acid synthase.
• Malaria, caused by Plasmodium falciparum, remains a significant global health challenge.
• Developing novel antimalarial agents targeting essential parasite pathways is crucial.

Purpose of the Study:

• To synthesize and evaluate TLM analogues for antimalarial activity against Plasmodium falciparum.
• To investigate the mechanism of action of TLM analogues, focusing on the Plasmodium falciparum KASIII enzyme.
• To explore the potential of TLM analogues against other parasitic protozoa.

Main Methods:

• Synthesis of TLM analogues, including alkylation at the C4 hydroxyl group.
• In vitro assessment of parasite growth inhibition for Plasmodium falciparum.
• Production and assay of Plasmodium falciparum KASIII (pfKASIII) enzyme activity.
• Evaluation of TLM analogues against Trypanosoma cruzi, T. brucei, and Leishmania donovani.

Main Results:

• Alkylation of the C4 hydroxyl group of TLM analogues resulted in over a 100-fold increase in antimalarial activity.
• Several TLM derivatives demonstrated improved inhibition of the pfKASIII enzyme compared to TLM.
• A weak correlation was observed between pfKASIII enzyme inhibition and parasite growth inhibition for some analogue series.
• TLM analogues also exhibited inhibitory effects on Trypanosoma cruzi, T. brucei, and Leishmania donovani.

Conclusions:

• The Plasmodium falciparum KASIII enzyme is unlikely to be the primary target of TLM analogues due to a lack of clear correlation between enzyme inhibition and parasite growth inhibition.
• TLM analogues represent a promising class of compounds with broad-spectrum antiparasitic potential, including activity against malaria and other protozoan parasites.
• Further research is warranted to elucidate the precise mechanism of action and optimize TLM analogues for therapeutic development.